Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Juno Therapeutics, Inc.JUNO · Entity 168572 | 10% owner | March 05, 2018 | March 06, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Juno Therapeutics, Inc.
Report date March 05, 2018 · Filed March 06, 2018
Jointly reported with CELGENE CORP /DE/, Celgene Switzerland LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 11,109,160 |
Reported balance
Holding disclosure · report date 2018-03-05 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 11,109,160 F1: These shares are owned directly by Celgene Switzerland LLC, a wholly-owned subsidiary of Celgene Corporation ("Celgene"). |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 88,118,707 |
Reported balance
Holding disclosure · report date 2018-03-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 88,118,707 F2: These shares are owned directly by Blue Magpie Corporation, a wholly-owned subsidiary of Celgene. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are owned directly by Celgene Switzerland LLC, a wholly-owned subsidiary of Celgene Corporation ("Celgene").
F2: These shares are owned directly by Blue Magpie Corporation, a wholly-owned subsidiary of Celgene.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
No transactions match
Try broader filters. Historical coverage is still being backfilled.
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.